Latent tuberculosis Infections and Infestations Tuberculosis
Conditions
Interventions
Agreement of three diagnostic tests for latent tuberculosis will be tested in haemodialysis patients. Blood samples are taken for:
1. Quantiferon-gold assay, an enzyme linked immunosorbent assay (ELIS
Sponsors
Gachon University of Medicine and Science (South Korea)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Chronic maintenance haemodialysis patients who continue to receive haemodialysis for more than three months in the Gil Medical Centre 2. Older than 18 years, and less than 80 years, either sex 3. Agrees to participate in this trial 4. Medical staff in the haemodialysis centre of the Gil Medical Centre
Exclusion criteria
Exclusion criteria: 1. Patients who suffer from skin diseases which may interfere with Mantoux test 2. Patients with an active infection, except tuberculosis 3. Patients who cannot make independent decision due to mental disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Skin test: positive or negative 2. Quantiferon-gold: positive or negative 3. T-spot test: positive or negative These outcomes will be measured on the day of testing. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Skin test: size of induration 2. Quantiferon-gold: concentration 3. T-spot test: number, mean area These outcomes will be measured on the day of testing. | — |
Countries
Korea, South
Outcome results
None listed